Grund Nicholas

Grund Nicholas is listed in filings as Chief Commercial Officer at Akebia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Akebia Therapeutics, Inc. (AKBA). The current snapshot covers public activity from Feb 4, 2025 to Feb 4, 2026. Reported amounts are shown as $74.5K to $451.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.